« Zurück
Startseite /
PSEN1 Peptide - N-terminal region (AAP44201)

PSEN1 Peptide - N-terminal region (AAP44201)

ArtNr	AAP44201
Hersteller	AVIVA Systems Biology
Menge	100 ug
Kategorie	Oncology Neuroscience Neural Lineage Markers Neuroinflammation Molecular Targets for Neuroscience Targets for Rodent Neurosciences Aging & Neurological Disorders Neural Signaling Protein Aggregation, Clearance & Misfolding Neural Adhesion Molecules Peptides & Proteins Immunohistochemistry Western Blot Peptides By Organ Colorectal Cancer Microglia Markers Glial Cell Markers Neuronal Cell Markers Oligodendrocyte Markers
Typ	Peptides
Format	Lyophilized powder
Applikationen	WB, IHC
Specific against	other
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	AD3, FAD, PS1, S182
Similar products	PSEN1
Lieferbar
Description	This is a synthetic peptide designed for use in combination with anti-PSEN1 antibody (Catalog #: ARP44201_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Gene symbol	PSEN1
Protein size	467
Molecular weight	53kDa
Product format	Lyophilized powder
Gene id	5663
Reconstitution and storage	Add 100ul of sterile PBS. Final peptide concentration is 1 mg/ml in PBS. For longer periods of storage, store at -20C. Avoid repeat freeze-thaw cycles.
Partner proteins	APH1A, APP, APP, APP, APP, CTNNB1, CTNND2, NCSTN, STX1A, STX5, CASP1, CASP3, CASP4, CASP7, APBA1, APH1A, APH1B, APP, BACE1, BCL2, BCL2L1, CASP1, CASP3, CASP4, CASP6, CASP7, CASP8, CDH1, CDK5, CIB1, CTNNA1, CTNNB1, CTNND1, CTNND2, DLL1, DOCK3, EFNB2, ERN1, FBXW7, FLNA, FLNB, GDI1, GFAP, GSK3B, HERPUD1, ICAM5, JUP, KCNIP3, MAPT, METTL2A, MTCH1, NCSTN, NOTCH1, NOTCH2, NOTCH3, NOTCH4, PIK3R1, PKP4, PRKACA, PRKCZ, PSEN1, PSENEN, RAB11A, SRSF2IP, TCF7L2, UBQLN1, YME1L1, APH1A, APP, BCL2, BCL2L1, CDH1, CIB1, CLSTN1, CTNNA1, CTNNB1, CTNND1, Ctnnb1, ERN1, FBXW7, FLNB, GFAP, GSK3B, HERPUD1, ICAM5, KCNIP3, KCNIP4, MAPT, NCSTN, NOTCH1, PKP4, PSEN1, PSEN2, PSENEN, PSENEN, TCF7L2, TRAF6, UBQLN1, YME1L1
Description of target	Alzheimer's disease (AD) patients with an inherited form of the disease carry mutations in the presenilin proteins (PSEN1; PSEN2) or in the amyloid precursor protein (APP). These disease-linked mutations result in increased production of the longer form o

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

AAP44201-datasheet.pdf

Sicherheitsdatenblatt anfordern

Einfache Bestellung Periodische Bestellung

Menge: 100 ug

lieferbar

Lieferung vsl. bis 28.08.2025

Express-Lieferung: 13 Tage sparen

Vergleichen

Auf den Wunschzettel

Angebot anfordern